Effects of Talampanel on Patients With Advanced Parkinson's Disease

- Dyskinesias | Parkinson Disease | Movement Disorders
- Completed

Study Title: Effects of Talampanel on Patients With Advanced Parkinson's Disease

Teva Identifier: IXL-202-18-189

ClinicalTrials.gov Identifier: NCT00036296

Study Status: Completed

Trial Condition(s): Dyskinesias | Parkinson Disease | Movement Disorders

Interventions: Drug: talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 40 Years to 85 Years

Trial Duration: 12/01/2006 - 02/01/2007

Phase: Phase 1/2

Study Type

Interventional